Immunogen Inc
IMGN
IMGN was delisted on the 9th of February, 2024.
190 hedge funds and large institutions have $806M invested in Immunogen Inc in 2023 Q1 according to their latest regulatory filings, with 22 funds opening new positions, 62 increasing their positions, 56 reducing their positions, and 30 closing their positions.
188% more call options, than puts
Call options by funds: $18.4M | Put options by funds: $6.38M
11% more repeat investments, than reductions
Existing positions increased: 62 | Existing positions reduced: 56
6% less funds holding
Funds holding: 202 → 190 (-12)
20% less capital invested
Capital invested by funds: $1B → $806M (-$197M)
27% less first-time investments, than exits
New positions opened: 22 | Existing positions closed: 30
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Janus Henderson Group
London,
|
+$56.7M |
| 2 |
Adage Capital Partners
Boston,
Massachusetts
|
+$27.8M |
| 3 |
Artisan Partners
Milwaukee,
Wisconsin
|
+$13.6M |
| 4 |
Morgan Stanley
New York
|
+$13.1M |
| 5 |
Millennium Management
New York
|
+$8.71M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DM
Deerfield Management
New York
|
-$31.5M |
| 2 |
Jennison Associates
New York
|
-$29.1M |
| 3 |
WP
Woodline Partners
San Francisco,
California
|
-$24.9M |
| 4 |
B
Braidwell
Stamford,
Connecticut
|
-$17.2M |
| 5 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
-$5.63M |
IMGN Hedge Fund Activity: Q1 2023 in Review
190 of the 6,283 institutional investors tracked by Wall St. Rank reported a position in Immunogen Inc (IMGN) for Q1 2023, worth a combined $806M — down 20% from $1B a quarter earlier.
Sellers outnumbered buyers: 30 funds closed out of IMGN and 22 opened new positions — a net loss of 8 holders — while 56 trimmed existing stakes and 62 added.
The largest buyer was Janus Henderson Group, adding an estimated $56.7M. The largest seller was Deerfield Management, exiting entirely with an estimated $31.5M sold.
- 190 institutional investors held Immunogen Inc (IMGN) as of Q1 2023, down from 202 in Q4 2022.
- Funds reported $806M of Immunogen Inc stock for Q1 2023, down 20% quarter-over-quarter.
- 22 funds opened new Immunogen Inc positions in Q1 2023 and 30 closed out, a net change of -8 holders.
- The largest Immunogen Inc buyer in Q1 2023 was Janus Henderson Group, an estimated $56.7M added.
- The largest Immunogen Inc seller in Q1 2023 was Deerfield Management, an estimated $31.5M sold.
Based on aggregated 13F filings for Q1 2023.